364 filings
Page 6 of 19
SC 13G
fulzjy
4 Jan 23
AVENUE THERAPEUTICS / SABBY MANAGEMENT ownership change
8:25am
SC 13G/A
n4z5ca 52il8ga
14 Dec 22
AVENUE THERAPEUTICS / Nantahala Capital Management ownership change
4:06pm
DEFA14A
g80aaxb rruz
18 Nov 22
Additional proxy soliciting materials
4:30pm
8-K
hdkylipa 3qtb8u
10 Nov 22
Avenue Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
4:29pm
8-K
gtsrao6lb 4i77wfu
8 Nov 22
Completion of Acquisition or Disposition of Assets
8:40am
8-K
4yukrsk 3hm
4 Nov 22
Departure of Directors or Certain Officers
4:25pm
SC 13D/A
g7lrrtp
19 Oct 22
AVENUE THERAPEUTICS / InvaGen Pharmaceuticals ownership change
7:26am
8-K
ln6hh1 wwy90msh2
18 Oct 22
Other Events
5:19pm
SC 13G
lpjvz9dxt2f9
17 Oct 22
AVENUE THERAPEUTICS / CVI Investments ownership change
12:01pm
SC 13G
z3wfwh8z6 jl
17 Oct 22
AVENUE THERAPEUTICS / INTRACOASTAL CAPITAL ownership change
6:01am
4
iry pfhw2jhuj698ggv
13 Oct 22
Change in insider ownership
8:52pm
8-K
tluv 5mvpe5k0ei
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
424B4
0opgx rtgrg7tj5ytss8
11 Oct 22
Prospectus supplement with pricing info
8:27am
EFFECT
r0h56243p2zm un1
7 Oct 22
Notice of effectiveness
12:15am
FWP
tpjqyihqiql w5
6 Oct 22
Free writing prospectus
4:05pm
CORRESP
gt0dfumj
5 Oct 22
Correspondence with SEC
12:00am